We found, using tumour cells where the E2F1 gene had been genetically inactivated combined with chemical ablation of PRMT5 enzyme activity, that E2F1 is important for PRMT5 to maintain cancer cell viability. The gene discussed is E2F1; the disease is neoplasm.